Proteolipid protein (PLP) is the major myelin membrane protein of the central nervous system. We have isolated a copy of an alternatively spliced PLP gene transcript from a mouse brain cDNA library that was screened for PLP-related sequences. The encoded 241-amino acid protein differs from PLP by an internal deletion of 35-amino acid residues (116-150) from the major hydrophilic domain. This PLP variant is identical with the DM-20 protein of myelin, previously described as a brain-specific myelin component and known to be related to PLP. We determined the corresponding nucleotide sequence of the rat PLP gene and found that DM-20 mRNA results when a second 5' splice site, located 105 nucleotides within the third exon of the primary PLP transcript, is utilized in precursor mRNA (pre-mRNA) splicing. This demonstrates that alternative 5' splice site selection can determine the protein product of a cellular gene. DM-20 mRNA is expressed in rat brain with approximately 50% abundance relative to PLP mRNA and appears to be developmentally coregulated.
Myelination in the mammalian central nervous system (CNS)
is the specialized function of differentiated oligodendrocytes and involves the coordinated expression of myelin-specific gene products. Proteolipid protein (PLP) is the most abundant myelin protein of the CNS and is a highly hydrophobic integral membrane protein (reviewed in ref. 1) . Its primary structure has been established by protein sequencing (2) (3) (4) and more recently from the cloning of PLP cDNAs from several species (5) (6) (7) (8) (9) (10) . A mutation in the mouse PLP gene is the primary genetic defect of the dysmyelinating mutant mouse jimpy (8) (9) (10) (11) (12) , which demonstrates the critical role of PLP in CNS myelin assembly.
Another CNS specific myelin protein of lower abundance has been termed "intermediate protein" or DM-20 (13) , which reflects its apparent molecular mass. Depending on the proteolipid extraction method (14) , DM-20 copurifies with PLP, but the two proteins can easily be separated by NaDodSO4 gel electrophoresis. PLP and the DM-20 protein are related by amino-and carboxyl-terminal amino acid sequence homology and immunological crossreactivity (1) . The exact structure of DM-20 and its relationship to PLP had been controversial, but recent evidence has suggested that DM-20 differs from PLP by an internal deletion of residues 100-140 (plus or minus a few amino acids) (15, 16) . To determine the exact relationship between PLP and DM-20 and to test the possibility that the DM-20 protein is a result of alternative PLP precursor mRNA (pre-mRNA) splicing, we screened a mouse brain cDNA library for PLP-related sequences. A full-length copy from such an alternatively spliced PLP mRNA was identified and shown to encode a variant PLP form. All evidence suggests that this variant proteolipid is the DM-20 protein of myelin. To analyze the mechanism of alternative splicing, we determined the sequence of the corresponding part of the rat PLP gene § and found that RNA processing involves alternative 5' splice site selection in the protein coding region of the primary PLP gene transcript, a splicing mechanism previously seen in the gene expression of DNA tumor viruses and a simple means of generating protein diversity.
MATERIALS AND METHODS
Animals. Timed-pregnant Sprague-Dawley rats (Charles River Breeding Laboratories) provided a source of postnatal 11-and 20-day and adult (over 50-day-old) brains. B6CBA mice were obtained from The Jackson Laboratory. Male 21-day-old mice were used for brain RNA extraction.
Isolation of RNA. Cytoplasmic RNA was isolated from fresh brains by extraction with phenol/chloroform/isoamyl alcohol (50:50:1) (17) and was enriched for poly(A)+ mRNA by passage over oligo(dT)-cellulose (18) . The RNA concentration of each preparation was determined by measuring the absorbance at 260 nm: a solution of 38 ,pg of RNA per ml was assumed to have an absorbance of 1.0. cDNA and Genomic Cloning. A mouse brain cDNA library was prepared from cytoplasmic poly(A)+ RNA of 21-day-old mice according to the cloning procedure of Okayama and Berg (19, 20) . The library was amplified prior to transformation in Escherichia coli MC1061 and had a complexity of approximately 105 independent transformants. Colony hybridization screening (21) was carried out using the 32p-labeled cDNA insert of the rat PLP clone p27 (5) . A genomic library made from rat liver DNA (22) was screened using a radioactively labeled cDNA fragment corresponding to the PLP coding region of clone p27. Positive isolates were mapped by restriction mapping and subcloned into pUC18 plasmid vectors (Pharmacia).
DNA Sequencing. Sequence analysis of 5' end-labeled fragments was accomplished using a modified version (23) of the partial chemical degradation method (24) .
RNA Protection Analysis. An 821-base-pair (bp) BamHIPst I fragment of the PLP coding region in p27 (nucleotides 45-866) was subcloned into the transcription vector pGEM-4 (Promega Biotec, Madison, WI). The plasmid was linearized with Bgl II (nucleotide 418 in p27) and, by using T7 RNA polymerase, antisense RNA transcripts were generated in vitro under the conditions suggested by the manufacturer. 
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Proc. Nati. Acad. Sci. USA 84 (1987) Hybridization with 1.0 ,ug of total cytoplasmic RNA from rat brain was carried out as described (25) . Only RNase A (Boehringer Mannheim) was used in the subsequent digestion step (40 , These fragment sizes were obtained (Fig. 2) ; their relative ratio (after correction for fragment length) indicates that DM-20 mRNA is expressed with nearly 50% abundance relative to PLP mRNA. Only a minor change in the ratio is observed between postnatal day 11 (46%) and adult (49%) brains, suggesting that both forms are coordinately expressed during early and late stages of myelination. The relative abundance of DM-20 mRNAs is slightly higher in normal mouse (60%) than in the jimpy mutant mouse (40%), which carries a mutation in the PLP gene that affects RNA splicing (8) To test possible models of alternative splicing, we determined the nucleotide sequence of the corresponding part of the rat PLP gene (Fig. 3) . A genomic library made from rat liver DNA in A Charon 4A was screened for PLP-positive clones using labeled p27 cDNA as a probe. Positive isolates were mapped by restriction analysis, subcloned into the plasmid vector pUC18, and partly sequenced. The sequence of subclone p214, which contained the region of interest, was compared with PLP and p1l cDNA sequences to provide the exon-intron organization around the alternative splice sites in the rat PLP gene (Fig. 3) Proc. Natd. Acad. Sci. USA 84 (1987) alternatively spliced forms. Inclusion of the complete third exon of the PLP gene after splicing results in PLP mRNA, which encodes the 276-amino acid major PLP. The alternatively spliced mRNA, which is expressed with about 50% abundance relative to PLP mRNA, lacks the 3' part of exon III and encodes the sequence of a related 241-amino acid proteolipid. We conclude that this PLP variant is identical to the previously described DM-20 protein for the following reasons: (i) PLP and DM-20 are two structurally (29) and immunologically (30) related CNS proteolipids that are found in myelin in a ratio similar to the relative abundances of the two alternatively spliced PLP mRNAs and are expressed with the same developmental time course. (ii) The deletion of 35 amino acids from the sequence of PLP would exactly account for the observed size difference between PLP and DM-20 of approximately 4 kDa on NaDodSO4/polyacrylamide gels (13) . (iii) The location of this deletion in the PLP sequence (residues 116-150) is consistent with the findings of Trifilieff et al. (16) , who have shown that DM-20 is not detectable with anti-peptide antibodies directed against residues 117-129 of PLP, whereas site-specific antibodies directed against other regions of PLP do crossreact with both proteolipids. From this and a protein chemical analysis (15) , it was proposed that DM-20 differs from PLP by the deletion of residues 100-140 (plus or minus a few amino acids).
PLP contains multiple membrane-spanning domains, and two models have been proposed for its orientation in the lipid bilayer (3, 31) . The part of PLP that is shown to be absent in DM-20 (residues 116-150) comprises a large portion of the major hydrophilic domain of the protein and exactly precedes the third membrane-embedded domain (Fig. 4) . Trifilieff (40) .
likely contributes to the extracellular compaction of the myelin sheath.
Splice Site Selection in the PLP Gene. We have determined the complete primary structure of DM-20 and demonstrated that it is encoded by a separate mRNA and is not simply a posttranslationally modified form of PLP. Two other classes of myelin proteins are also derived from complex transcription units: five forms of myelin basic protein (32) (33) (34) and two forms of the myelin-associated glycoprotein (35) . In both cases, alternative splicing involves the differential exclusion of separate exons, a mechanism observed in a number of eukaryotic genes (for review, see ref. 36 ). Generating two proteins by selection of alternative 5' splice sites, to our knowledge, has been described only for SV40 gene transcripts and in related viral systems. The expression of both the large and small tumor antigens of SV40, which share the amino terminus of the protein, results from the use of two alternative splice sites in the early gene transcript (37) . We, here, describe an apparently similar 5' splice site selection in the protein coding region of a cellular gene, a simple mechanism to change the protein product of a gene and to generate protein diversity.
Assuming that both mRNA forms are equally stable in vivo, PLP mRNA results from an about 2-fold higher splicing efficiency of the downstream splice site. Several reports have shown that in vitro a "strong" alternative splice site contains a higher degree of homology to the consensus sequences (38, 39) . By comparing the nucleotide sequences of the two alternative donor sites of the PLP gene, we find no obvious difference in the match between the consensus 5' splice site (40) and both the PLP and the DM-20 donor splice site of exon III (Fig. 5) . In in vitro systems, upstream 5' donor sites are more frequently used than identical alternative splice sites downstream (38, 41) . However, such a position effect is known to be sequence and distance dependent (42) . There is, so far, no evidence for a differential expression of PLP and DM-20 mRNAs. Whether a cis-acting splice site "signal strength" and "position effect" alone can sufficiently explain the in vivo observed ratio of splice site selection awaits further characterization. We noticed that both alternative splice sites of exon III show a decreased homology to the consensus sequence as compared to splice junctions of all the remaining exons in the PLP gene (28) .
The functional difference between PLP and DM-20 for the development of compact myelin is unknown. Most likely, PLP was the primary proteolipid and the DM-20 form developed later in evolution (43) , following the introduction of an alternative splice site into the protein coding region. In more primitive vertebrates, such as lungfish, Waehnelt and coworkers detected a single myelin protein that immunologically crossreacts with antibodies against mammalian PLP (44) . This protein is glycosylated and has an apparent molecular mass very similar to that of rat brain PLP. It may, therefore, represent the evolutionary precursor of both PLP and DM-20.
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